Pfizer
A regional affiliate of a global biopharmaceutical company focused on discovery, development and distribution of medicines, vaccines and therapeutics. The organisation publishes patient education and product information, provides medical information services and adverse event reporting, engages in public health policy discussions, and states research focus areas including internal medicine, inflammation & immunology, oncology, rare disease, vaccines and hospital therapies.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US-12616744-B2
View DetailsCombinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases
US-12611401-B2
View Details
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US-12616744-B2
View DetailsCombinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases
US-12611401-B2
View DetailsProducts
Medicines and vaccines (commercial portfolio)
A portfolio of medicines, vaccines and therapeutics for a range of conditions from common to complex diseases, used for prevention and treatment.
Medicines and vaccines (commercial portfolio)
A portfolio of medicines, vaccines and therapeutics for a range of conditions from common to complex diseases, used for prevention and treatment.
Services
Provision of product information and clinical answers via a dedicated medical information website, phone and text channels for HCP and consumer enquiries.
Online and email/phone channels for reporting suspected adverse events to support pharmacovigilance and safety monitoring.
Public-facing information on clinical trials and how to find and participate in trials.
Online search tools for Consumer Medicine Information and Product Information targeted at consumers and healthcare professionals.
Provision of product information and clinical answers via a dedicated medical information website, phone and text channels for HCP and consumer enquiries.
Online and email/phone channels for reporting suspected adverse events to support pharmacovigilance and safety monitoring.
Public-facing information on clinical trials and how to find and participate in trials.
Online search tools for Consumer Medicine Information and Product Information targeted at consumers and healthcare professionals.
Expertise Areas
- Therapeutic R&D (internal medicine, oncology, inflammation & immunology, rare disease, vaccines, hospital therapies)
- Vaccine development
- Anti-infectives and antimicrobial resistance
- Clinical trial management and operations
Key Technologies
- Vaccine development
- Antiviral and anti-infective drug development
- Biologics development
- Small-molecule therapeutics
News & Updates
Report highlighting the importance of timely antiviral treatment within five days of COVID-19 symptom onset for people aged 50 and over.
Report calling for a Life Sciences Vision for Australia to prioritise the life sciences sector in national economic growth.
Report highlighting the importance of timely antiviral treatment within five days of COVID-19 symptom onset for people aged 50 and over.
Report calling for a Life Sciences Vision for Australia to prioritise the life sciences sector in national economic growth.